Title of article :
Association of Perilipin and Insulin Receptor Substrate-1 Genes Polymorphism
with Lipid Profiles, Central Obesity, and Type 2 Diabetes in a Sample of an
Iranian Population
Author/Authors :
Noorzehi Nafiseh نويسنده Department of Biology, Faculty of Science, University of
Zabol, Zabol, IR Iran , Saravani Ramin نويسنده Department of Clinical Biochemistry, Cellular and Molecular Research Center, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran , Galavi Hamid Reza نويسنده Student Scientific Research Center, Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran , Ranjbar Nasrin نويسنده Cellular and Molecular Research Center, Department of Clinical Biochemistry, School of Medicine, Zahedan University of Medical Sciences, Zahedan, IR Iran , Lotfian Sargazi Marzieh نويسنده Department of Clinical Biochemistry, School of Medicine,
Zahedan University of Medical Sciences, Zahedan, IR
Iran
Abstract :
Background Since insulin receptor substrate-1
(IRS-1) is the main substrate of the insulin receptor
tyrosine kinase and has been detected to activate phosphatidylinositol
(PI) 3-kinase and promote GLUT4 translocation, the
IRS-1 gene is a possible candidate for development of
type2 diabetes, insulin resistance, and obesity. Preilipin
(PLIN) coats intracellular lipid droplets and
modulates adipocyte lipolysis. Objectives In this study, we investigated
whether insulin receptor substrate-1 (IRS-1) and
Perilipin (PLIN) genes polymorphism were associated
with Type 2 diabetes (T2D), obesity, and lipid profiles in a sample of
the Iranian population (Southeast of Iran). Methods In this randomized
case-control study (Feb, 2016 to Sep, 2016), we genotyped 200 patients
with T2D and the same number (200) of controls by using the combined
nested-polymerase chain reaction (PCR) as well as the amplification
refractory mutation system (ARMS)-PCR for IRS-1
variant and Tetra-ARMS-PCR for PLIN variant in
southeast Iran (Zahedan). Results The polymorphism of 4578621 in the
PLIN gene was associated with T2D. GG genotype and G
allele at rs4578621of PLIN gene were significantly
higher in patients than in controls (for the G allele: OR = 2.31, 95%CI
= 1.55 - 3.46, P < 0.0001; for the GG genotype: OR = OR = 2.67,
95%CI = 1.71-4.19, P<0.0001). Furthermore, women with fast blood
glucose (FBG) < 110 mg/dL are in protection of diabetes (P
< 0.001, OR = 0.561 (0.430 - 0.733), for women, (P = 0.002, OR =
0.481 95%CI: 0.305 - 0.756), for FBG, (P = 0.002, OR = 0.591, 95%CI =
0.422 - 0.829), for triglyceride (TG) < 130 mg/dL, and (P =
0.001, OR. = 0.563, 95%CI = 0.407 - 0.780) for TG ≥ 130. On the other
hand, the polymorphism of 2943641 in IRS-1 gene was
not associated with T2D (P = 0.08). However, the frequencies of the risk
A allele at rs29436411of IRS-1 was significantly
higher in patients than in controls (G allele: OR = 0.55, 95% CI = 0.36
- 0.848, P = 0.0086). Also detected, BMI ≥ 25 is a risk factor for
diabetes in rs29436411of IRS-1 gene (P = 0.024, OR =
1.604 95%CI = 1.063 - 2.420). Conclusions The rs2943641 polymorphism of
the IRS-1 gene is a major genetic determinant of
obesity but not Type 2 diabetes and lipid profiles. The rs4578621
polymorphism of the PLIN gene related with T2D and TG
but not obesity.